These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 13121631)

  • 1. The fibrinolytic system and inflammation.
    UNGAR G
    Rev Can Biol; 1953 Oct; 12(2):253-8; discussion, 258-61. PubMed ID: 13121631
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of caseinolytic and fibrinolytic assays for plasmin (fibrinolysin) in "fibrinolytic agents".
    Moser KM; Frey MB
    Thromb Diath Haemorrh; 1966 Jan; 15(1):252-72. PubMed ID: 4224094
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of bioresolving microspheric preparations of immobilized fibrinolysin on the fibrinolysis system].
    Bessolitsyna LA; Mazaev AB; Markosian RA; Suvorov AV; Torchilin VP
    Biull Eksp Biol Med; 1980; 89(1):16-8. PubMed ID: 6445763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro studies to elucidate the fibrinolytic activity in cerebrospinal fluid altered by inflammation and hemorrhage and having pathologic protein values].
    Hindersin P; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1977 Aug; 29(8):465-73. PubMed ID: 144927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental urinary tract infections. I. On connection between "Bradykinin" and fibrinolytic enzyme system].
    Kono N
    Nihon Hinyokika Gakkai Zasshi; 1965 Dec; 56(12):1323-32. PubMed ID: 4223599
    [No Abstract]   [Full Text] [Related]  

  • 6. Insolubilized activators of the fibrinolysin system. In vitro studies.
    Ambrus CM; Ambrus JL; Roholt OA; Meyer BK; Shields RR
    J Med; 1972; 3(4):270-81. PubMed ID: 4264161
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of drug-induced plasminemia on the readiness for inflammation].
    Nissen H; Feyen H; Rasche H; Hilgard P; Hiemeyer V
    Z Rheumaforsch; 1971; 30(1):26-33. PubMed ID: 4256437
    [No Abstract]   [Full Text] [Related]  

  • 8. Molar concentrations of fibrinolytic components, especially free fibrinolysin, in vivo.
    Nanninga LB
    Thromb Diath Haemorrh; 1975 Apr; 33(2):244-55. PubMed ID: 124474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of alpha-adrenoceptor antagonist dihydroergotoxin in experimental anticoagulant and fibrinolytic therapy.
    Kalishevskaya TM; Golubeva MG; Bashkov GV
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):157-61. PubMed ID: 2459012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The occurrence of a fibrinolytic system in the placenta].
    WILLE P
    Folia Haematol (Frankf); 1957 Apr; 1(3):230-40. PubMed ID: 13438046
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of a combination of fibrinolysin, heparin and a fibrinolysin-heparin complex with dihydroergotoxine on thrombolysis].
    Kalishevskaia TM; Golubeva MG; Bashkov GV; Vinter VB
    Fiziol Zh (1978); 1988; 34(3):88-93. PubMed ID: 2842201
    [No Abstract]   [Full Text] [Related]  

  • 12. [The place of fibrinolytic drugs in the treatment of vascular disorders].
    SALMON J
    Rev Med Liege; 1963 May; 18():316-7. PubMed ID: 13991152
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinolytic enzyme system vis-a-vis obesity.
    Laha PN
    J Assoc Physicians India; 1977 Feb; 25(2):159-61. PubMed ID: 144111
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Experimental and clinical contribution].
    Panazzolo A; Giambanco V; Pattarelli M; Scarpa F
    Haematol Lat; 1967; 10(4):409-22. PubMed ID: 4232988
    [No Abstract]   [Full Text] [Related]  

  • 15. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
    Okamoto U
    Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
    [No Abstract]   [Full Text] [Related]  

  • 16. Decrease of metastases of carcinosarcoma Walker 256 with irradiation and heparin or fibrinolytic agents.
    AGOSTINO D; CLIFFTON EE
    Radiology; 1962 Nov; 79():848-55. PubMed ID: 14011262
    [No Abstract]   [Full Text] [Related]  

  • 17. [The relationship between exercise and the fibrinolytic enzyme system. 1. The relationship between the fibrinolytic enzyme system in the blood and microhematuria due to exercise].
    Kono N; Maatsuzaki S
    Nihon Hinyokika Gakkai Zasshi; 1968 Oct; 59(10):877-93. PubMed ID: 4237220
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies of the fibrinolytic system in experimental bleeding and retransfusion according to the changes in thermal condition and in experimental jaundice].
    Tada T
    Nihon Geka Hokan; 1968 Sep; 37(5):657-72. PubMed ID: 4237088
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of fibrinolytic agents. Present status in the treatment of cardiovascular disease.
    KATZ LN
    Calif Med; 1963 Apr; 98(4):204-6. PubMed ID: 14031317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterio-venous differences in the components of the fibrinolytic enzyme system.
    Ogston D; Ogston CM; Bennett NB
    Thromb Diath Haemorrh; 1966 Jul; 16(1):32-7. PubMed ID: 4229628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.